{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:05:25Z","timestamp":1784689525205,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"9","funder":[{"name":"Swedish Heart & Lung Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100018442","name":"Carl Bennet AB","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100018442","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Klebergska Foundation, the Tornspiran Foundation, the Scientific Council of Halland Region, the Southern Regional Healthcare Committee, the Swedish Stroke Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stockholm County Council","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Bristol Myers Squibb -Pfizer","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate adherence and adherence consistency to the handheld ECG device-based screening protocol and their association with adverse cerebral and cardiovascular outcomes in two systematic atrial fibrillation (AF) screening programmes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In 2012 (Systematic ECG Screening for Atrial Fibrillation Among 75-Year Old Subjects in the Region of Stockholm and Halland, Sweden (STROKESTOP) study) and 2016 (Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide (STROKESTOP II) study), half of all 75- and 76-year-old inhabitants of up to two Swedish regions were invited to participate in a systematic AF screening programme. Participants were instructed to perform 30-second measurements twice daily in STROKESTOP and four times daily in STROKESTOP II for 2 weeks. Adherence was defined as the number of measurements performed divided by the number of measurements asked, whereas adherence consistency was defined as the number of days with complete registrations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 6436 participants (55.7% female) from STROKESTOP and 3712 (59.8% female) from STROKESTOP II were included. Median adherence and adherence consistency were 100 (92\u2013100)% and 12 (11\u201313) days in STROKESTOP and 90 (75\u201398)% and 8 (3\u201311) days in STROKESTOP II. Female sex and lower education were factors associated with both optimal adherence and adherence consistency in both studies. In STROKESTOP, low adherence and adherence consistency were associated with higher risk of adverse cerebral and cardiovascular outcomes (HR for composite primary endpoint 1.30 (1.11 to 1.51), p=0.001), including stroke (HR 1.68 (1.22 to 2.32), p=0.001) and dementia (1.67 (1.27 to 2.19), p&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adherence to twice daily handheld ECG measurements in STROKESTOP was higher than to four times daily measurements in STROKESTOP II. Female sex and lower educational attainment were associated with \u2265100% adherence and adherence consistency. Low adherence and adherence consistency were associated with a higher risk of adverse outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323522","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:44:00Z","timestamp":1704847440000},"page":"626-634","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-3333","authenticated-orcid":false,"given":"Rachel M J","family":"van der Velden","sequence":"first","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Bonander","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-5337","authenticated-orcid":false,"given":"Harry J G M","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Kemp-Gudmundsdottir","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-7215","authenticated-orcid":false,"given":"Johan","family":"Engdahl","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-0824","authenticated-orcid":false,"given":"Dominik","family":"Linz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands"},{"name":"Department of Biomedical Sciences, University of Copenhagen, Kobenhavn, Denmark"},{"name":"Center for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Svennberg","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"2025092014422669000_110.9.626.1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2025092014422669000_110.9.626.2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman","year":"2016","journal-title":"The Lancet"},{"key":"2025092014422669000_110.9.626.3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025092014422669000_110.9.626.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"2025092014422669000_110.9.626.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422"},{"key":"2025092014422669000_110.9.626.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"2025092014422669000_110.9.626.7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euac038","article-title":"How to use Digital devices to detect and manage arrhythmias: an EHRA practical guide","volume":"24","author":"Svennberg","year":"2022","journal-title":"EP Europace"},{"key":"2025092014422669000_110.9.626.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213198","article-title":"Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis","volume":"14","author":"Petryszyn","year":"2019","journal-title":"PLoS One"},{"key":"2025092014422669000_110.9.626.9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2022.07.015","article-title":"Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials","volume":"105","author":"Elbadawi","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2025092014422669000_110.9.626.10","doi-asserted-by":"crossref","DOI":"10.2196\/13641","article-title":"Accuracy of mHealth devices for atrial fibrillation screening: systematic review","volume":"7","author":"Giebel","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"2025092014422669000_110.9.626.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01941-9"},{"key":"2025092014422669000_110.9.626.12","doi-asserted-by":"crossref","unstructured":"Gawalko M , Hermans A , Van Der Velden R , et al . Patient motivation and adherence to an on-demand App-based heart rate and rhythm monitoring for atrial fibrillation management: data from the Telecheck-AF project. Eur J Cardiovasc Nurs 2022;24.(Supplement_1) doi:10.1093\/europace\/euac053.587","DOI":"10.1093\/europace\/euac053.587"},{"key":"2025092014422669000_110.9.626.13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/heartjnl-2022-321346","article-title":"Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation","volume":"109","author":"van der Velden","year":"2022","journal-title":"Heart"},{"key":"2025092014422669000_110.9.626.14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2020.12.077","article-title":"Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation","volume":"329","author":"Hermans","year":"2021","journal-title":"Int J Cardiol"},{"key":"2025092014422669000_110.9.626.15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/europace\/eus217","article-title":"Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)","volume":"15","author":"Friberg","year":"2013","journal-title":"EP Europace"},{"key":"2025092014422669000_110.9.626.16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/europace\/euw319","article-title":"Stepwise mass screening for atrial fibrillation using N-terminal pro B-type natriuretic peptide: the STROKESTOP II study design","volume":"19","author":"Engdahl","year":"2017","journal-title":"Europace"},{"key":"2025092014422669000_110.9.626.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014343"},{"key":"2025092014422669000_110.9.626.18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a Multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"The Lancet"},{"key":"2025092014422669000_110.9.626.19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/europace\/euz255","article-title":"Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study","volume":"22","author":"Kemp Gudmundsdottir","year":"2020","journal-title":"Europace"},{"key":"2025092014422669000_110.9.626.20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur Heart J"},{"key":"2025092014422669000_110.9.626.21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish National inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2025092014422669000_110.9.626.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01402.x"},{"key":"2025092014422669000_110.9.626.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030583"},{"key":"2025092014422669000_110.9.626.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01979-w"},{"key":"2025092014422669000_110.9.626.25","doi-asserted-by":"crossref","unstructured":"van de Lande ME , Rama RS , Koldenhof T , et al . Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study. Europace 2023;25. doi:10.1093\/europace\/euad058","DOI":"10.1093\/europace\/euad058"},{"key":"2025092014422669000_110.9.626.26","doi-asserted-by":"crossref","first-page":"107284","DOI":"10.1016\/j.ypmed.2022.107284","article-title":"Factors predicting participation and potential yield of screening-detected disease among non-participants in a Swedish population-based atrial fibrillation screening study","volume":"164","author":"Gudmundsdottir","year":"2022","journal-title":"Prev Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:47:02Z","timestamp":1758404822000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,4,15]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/heartjnl-2023-323522"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323522","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]}}}